Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas
✍ Scribed by Tomás García-Caballero; Hichem M. Mertani; Anne Lambert; Rosalía Gallego; Máximo Fraga; Elena Pintos; Jerónimo Forteza; Michèle Chevallier; Peter E. Lobie; Barbara K. Vonderhaar; Andrés Beiras; Gérard Morel
- Book ID
- 111637542
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 373 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0969-711X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Growth hormone (GH) and prolactin (PRL) exert their regulatory functions in the mammary gland by acting on specific receptors. Using isotopic in situ hybridization and immunohistochemistry, we have localized the expression of hGH receptor (hGHR) and hPRL receptor (hPRLR) in a panel of human breast d
## Republic of China Hepatocellular carcinoma is a hormone-sensitive tumor. It has been reported that thyroxine and prolactin significantly stimulated hepatoma growth, whereas growth hormone failed to do so. To learn whether the growth hormone receptor is present in human hepatocellular carcinoma,
To understand the expression and role of thyroid hormone nuclear receptors (TRs) in hepatocarcinogenesis, we characterized the TRs in 16 human hepatocellular carcinoma (HCC) specimens. The full-length cDNAs for the two TR subtypes, a1 and b1, were cloned from several tumors by reverse transcription±